scispace - formally typeset
M

M. Jackson

Researcher at Merck & Co.

Publications -  12
Citations -  1378

M. Jackson is an academic researcher from Merck & Co.. The author has contributed to research in topics: Streptomyces & Fermentation. The author has an hindex of 9, co-authored 12 publications receiving 1320 citations.

Papers
More filters
Journal ArticleDOI

Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces

TL;DR: Phosphonomycin is a newly discovered antibiotic produced by streptomycetes that is effective, when administered by the oral route, to mice infected with Gram-positive or Gram-negative microorganisms.
Journal ArticleDOI

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

TL;DR: A new beta-lactam antibiotic, named thienamycin, was discovered in culture broths of Streptomyces MA4297, and subsequently determined to be a hitherto unrecognized species, is designated StrePTomyces cattleya (NRRL 8057).
Journal ArticleDOI

Cephamycins, a New Family of β-Lactam Antibiotics I. Production by Actinomycetes, Including Streptomyces lactamdurans sp. n

TL;DR: A number of actinomycetes isolated from soil were found to produce one or more members of a new family of antibiotics, the cephamycins, which are structurally related to cephalosporin C.
Journal ArticleDOI

Epithienamycins-novel beta-lactams related to thienamycin. I. Production and antibacterial activity.

TL;DR: Six major epithienamycin components, and xanthomycin, have been isolated from fermentation broth, and all six components show activity in vitro versus a broad spectrum of bacterial species.